Provivi, Inc. – Trademark Portfolio
Entity Type: 03
Provivi, Inc. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. Currently, 6 trademarks are registered and 1 is pending. Notable registered marks include PHERON, PROVIVI, PHEROGEN, INTERPHERE, and PROVIVI FAW. The owner is based in Santa Monica, CA.
1701 Colorado Avenue
Santa Monica, CA 90404
Showing of trademarks Trademarks
Trademark Classifications
Provivi, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Provivi, Inc. have?
Provivi, Inc. has 12 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 pending, 5 abandoned.
What trademark classes does Provivi, Inc. file in?
Provivi, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Provivi, Inc.'s most well-known trademarks?
Provivi, Inc.'s registered trademark portfolio includes well-known marks such as PHERON, PROVIVI, PHEROGEN, INTERPHERE, and PROVIVI FAW. These are among 6 currently registered trademarks in the portfolio.
What is Provivi, Inc.'s trademark registration success rate?
Provivi, Inc. has a 55% trademark registration rate, with 6 out of 11 resolved applications resulting in successful registration. Currently, 1 application is pending review.